The panel of compounds synthesized was initially evaluated for cytotoxic effects on human estrogen and progesterone receptor positive BC cell line MCF-7, triple-negative MDA-MB-231, and the promyelocytic leukemia cell line HL-60. This evidence concerns the gene PGR and breast cancer.